PlainRecalls
FDA Drug Low Class III Terminated

Montelukast Sodium Oral Granules, 4 mg pouch, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV --- NDC 0378-6040-93

Reported: June 21, 2017 Initiated: May 9, 2017 #D-0920-2017

Product Description

Montelukast Sodium Oral Granules, 4 mg pouch, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV --- NDC 0378-6040-93

Reason for Recall

Failed Impurities/Degradation Specifications; out of specification results for Sulphoxide Impurity and Total Impurities

Details

Units Affected
11,624 pouches
Distribution
Nationwide
Location
Morgantown, WV

Frequently Asked Questions

What product was recalled?
Montelukast Sodium Oral Granules, 4 mg pouch, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV --- NDC 0378-6040-93. Recalled by Mylan Pharmaceuticals Inc.. Units affected: 11,624 pouches.
Why was this product recalled?
Failed Impurities/Degradation Specifications; out of specification results for Sulphoxide Impurity and Total Impurities
Which agency issued this recall?
This recall was issued by the FDA Drug on June 21, 2017. Severity: Low. Recall number: D-0920-2017.